Abstract
It is currently controversial whether all the brain damage in alcohol abusers in the result of thiamine deficiency (Wernicke-Korsakoff's disease) or whether, in addition, alcohol abuse may affect the brain by other mechanisms as well. The purpose of this study was to determine if alcohol abuse affects muscarinic cholinergic and benzodiazepine receptors in histologically normal brains obtained at autopsy in a general hospital population. Patients were excluded from this study if they had clinical brain diseases (including Wernicke's disease), died in coma, or had liver disease, significant brain atrophy, or dementia severe enough to require institutionalization. We found that muscarinic cholinergic synaptic receptor density determined with [3H] quinuclidinly benzilate was decreased by 40% in homogenates of the tempeoral cortex of 26 alcohol abusers compared with 26 matched nonalcoholic controls. The affinities of the muscarinic receptors were not significantly different between the two groups. In contrast, receptor densities and affinities of benzodiazepine receptors determined with [3H]flunitrazepam were not significantly different in the two groups. Age and death-autopsy time interval had no significant effects on either wet tissue protein concentrations, yields of protein after centrifugation, or receptor binding. The contributions of age and time interval were each less than 2% of the total variance of protein concentrations and receptor binding. When patients were excluded or included who had received cholinergic, anti-cholinergic, or benzodiazepine medications before death, no significant effects on the final results were observed. Pneumonia, known to be associated with acute hypoxia, and chronic obstructive pulmonary disease, known to be associated with chronic hypoxia, where approximately equally distributed between the two groups and had no significant effects on the results reported here. The loss of muscarinic and the sparing of benzodiazepine receptors occurs in the temporal cortex of histologically normal brains in the absence of significant atrophy and of gross dementia. This means that these changes are early in the development of an alcohol encephalopathy. We have previously reported a decrease in both muscarinic and benzodiazepine receptor binding in the frontal cortex and a decreasing muscarinic but not benzodiazepine receptors in the temporal cortex of alcohol abusers. Taken together, these findings suggest that alcohol neurotoxicity does not simply result in a random loss of neurons and/or their associated synapses with their receptors. Instead, different types of receptors, depending upon their location in different brain regions, are specifically affected or spared. This suggests the involvement of region- and receptor-specific mechanisms in chronic alcohol toxicity. These and other changes in synaptic receptors may be the molecular basis for some of the specific behavior patterns of certain alcohol abusers.
Similar content being viewed by others
References
Altura, B. M., and Altura, B. T. (1987). Peripheral and cerebrovascular actions of ethanol, acetaldehyde, and acetate: Relationship to divalent cations.Alcohol. Clin. Exp. Res. 11: 99–111.
Antuono, P., Sorbi, S., Bracco, L., and Fusco, T. A. (1980). Discrete sampling technique in senile dementia of the Alzheimer type and alcoholic dementia: Study of the cholinergic system. In Amaducci, L., Davison, A. N., and Antuono, P. (eds.),Aging of the Brain and Dementia. Aging. Vol. 13, Raven Press, New York, pp. 151–158.
Bachrach, L. L. (1976a). Educational level of male admissions with alcohol disorders to state and county mental hospitals—1972. NIMH Mental Health Statistical Note, No. 123.
Bachrach, L. L. (1976b). Characteristics of diagnosed and missed alcoholic male admissions to state and county mental hospitals—1972. NIMH Mental Health Statistical Note, No. 124.
Bartus, R. T., Dean, R. L., III, Beer, B., and Lippa, A. S. (1982). The cholinergic hypothesis of geriatric memory dysfunction.Science 217: 408–417.
Biggio, G., and Costa, E. (1983).Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology, Raven Press, New York.
Bowen, D. M., Smith, C. G., White, P., Goodhardt, M. J., Spillane, J. A., Flack, R. H. A., and Davidson, A. N. (1977a). Chemical pathology of the organic dementias. I. Validity of biochemical measurements on human post-morten brain specimens.Brain 100: 397–426.
Bowen, D. M., Smith, C. G., White, P., Flack, R. H. A., Carrasco, L. H., Gedye, J. L., and Davidson, A. N. (1977b). Chemical pathology of the organic dementias. II Quantitative estimation of cellular changes in post-mortem brains.Brains 100: 427–453.
Braestrup, C., and Nielsen, M. (1980). Multiple benzodiazepine receptors.Trends Neurosci. 301–303.
Burt, D. R., Creese, I., and Snyder, S. H. (1977). Antischizophrenic drugs: Chronic treatment elevates dopamine receptor binding in brain.Science 196: 326–328.
Carlen, P. L., Wortzman, G., Holgate, R. C., Wilkinson, D. A., and Rankin, J. G. (1978). Reversible cerebral atrophy in recently abstinent chronic alcoholics measured by computerized tomography scans.Science 200: 1076–1078.
Centerwall, B. S., and Criqui, M. H. (1978). Prevention of the Wernicke-Korsakoif syndrome: A costbenefit analysis.N. Engl. J. Med. 299: 285–289.
Creese, I., and Sibley, D. R. (1981). Receptor adaptations to centrally acting drugs.Annu. Rev. Pharmacol. Toxicol. 21: 357–391.
Davies, P., and Verth, A. H. (1978). Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.Brain Res. 138: 385–392.
El-Fakahany, E., and Richelson, R. (1983). Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain.Br. J. Pharmacol. 78: 97–102.
Enna, S. J., Bennett, J. P., Jr., Bylund, D. B., Creese, I., Burt, D. R., Charness, M. E., Yamamura, H. I., Simantov, R., and Snyder, S. H. (1977). Neurotransmitter receptor binding: Regional distribution in human brain.J. Neurochem. 28: 233–236.
Epstein, P. S., Pisani, V. D., and Fawcett, J. A. (1977). Alcoholism and cerebral atrophy.Alcohol. Clin. Exp. Res. 1: 61–65.
Feierman, D. E., Winston, G. W., and Cederbaum, A. I. (1985). Ethanol oxidation by hydroxyl radicals: Role of iron chelates, Superoxide, and hydrogen peroxide.Alcohol. Clin. Exp. Res. 9: 95–102.
Figueroa, W. G., Sargent, F., Imperiale, L., Morey, G. R., Paynter, C. R., Vorhaus, L. J., and Kark, R. M. (1953). Lack of avitaminosis among alcoholics: Its relation to fortification of cereal products and general nutrition status of the population.J. Clin. Nutr. 1: 79–199.
Francis, P. T., Palmer, A. M., Sims, N. R., Bowen, D. M. et al. (1985). Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.N. Engl. J. Med. 313: 7–11.
Freund, G. (1970). Impairment of shock avoidance learning after long-term alcohol ingestion in mice.Science 168: 1599–1601.
Freund, G. (1980). Benzodiazepine receptor loss in brains of mice after chronic alcohol consumption.Life Sci. 27: 987–992.
Freund, G. (1982). Interactions of aging and chronic alcohol consumption on the central nervous system. In Wood, W. G., and Elias, M. F. (eds.),Alcoholism and Aging: Advances in Research CRC Press, Boca Raton; Fia., pp. 131–148.
Freund, G. (1983). Neurotransmitter function in relation to aging and alcoholism. In Hartford, J., and Samorajski, T. (eds.),Alcoholism in the Elderly, Raven Press, New York, pp. 65–83.
Freund, G. (1984). Biomedical causes of alcohol abuse.Alcohol 1: 129–131.
Grant, I., Prigatano, G. P., Heaton, R. K., McSweeny, A. J., Wright, E. C., and Adams, K. M. (1987). Progressive neuropsychologic impairment and hypoxemia: Relationship in chronic obstructive pulmonary disease.Arch. Gen. Psychiat. 44: 999–1006.
Hanly, P. J., Roberts, D., Dobson, K., and Light, R. B. (1987). Effect of indomethacin on arterial oxygenation in critically ill patients with severe bacterial pneumonia.Lancet 1: 351–354.
Harper, C., and Kril, J. (1985a). Brain atrophy in chronic alcoholic patients: A quantitative pathological study.J. Neurol. Neurosurg. Psychiat. 48: 211–217.
Harper, C. G., Kril, J. J., and Holloway, R. L. (1985b). Brain shrinkage in chronic alcoholics: A pathological study.Br. Med. J. 290: 501–514.
Hooper, M. W., and Vogel, F. S. (1976). The limbic system in Alzheimer's disease. A neuropathologic investigation.Am. J. Pathol. 85: 1–20.
Horvath, T. B. (1975). Clinical spectrum and epidermiological features of alcoholic dementia. In Rankin, J. G. (ed.),Alcohol, Drugs and Brain Damage, Addiction Research Foundation, Toronto, pp. 1–16.
Johnson, J. L., Adinoff, B., Bisserbe, J. C., Martin, P. R., Rio, D., Rohrbaugh, J. W., Zubovic, E., and Eckardt, M. J. (1986). Assessment of alcoholism-related organic brain syndromes with positron emission tomography.Alcohol. Clin Exp. Res. 10: 237–240.
Katzman, R. (1986). Alzheimer's disease.N. Engl. J. Med. 314: 964–973.
Katzman, R., Terry, R. D., and Bick, K. L. (1978).Alzheimer's Disease: Senile Dementia and Related Disorders, Raven Press, New York.
Klepner, C. A., Lippa, A. S., Benson, D. I., Sano, M. C., and Beer, B. (1979). Resolution of two biochemi cally and pharmacologically distinct benzodiazepine receptors.Pharm. Biochem. Behav. 11: 457–462.
Laposada, E. A., and Lange, L. G. (1986). Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse.Science 231: 497–499.
Lelbach, W. K. (1974). Organic pathology related to volume and pattern of alcohol use. In Gibbins, R. J., Israel, Y., Kalant, H., Popham, R. E., Schmidt, W., and Smart, R. G. (eds.),Research Advances in Alcohol and Drug Problems, John Wiley, New York, pp. 93–198.
Lieber, C. S. (1984). Alcohol-nutrition interaction: 1984 update.Alcohol 1: 151–157.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent.J. Biol. Chem. 193: 265–275.
Luabeya, M. K., Maloteaux, J., and Laduron, P. M. (1984). Regional and cortical laminar distributions of serotonin S2, benzodiazepine, muscarinic, and dopamine D2 receptors in human brain.J. Neurochem. 43: 1068–1071.
Luna, L. G. (eds.) (1968).Manual of Histological Staining Methods of the Armed Forces Institute of Pathology, 3rd ed., McGraw-Hill, New York.
Martz, A., Deitrich, R. A., and Harris, R. A. (1983). Behavioral evidence for the involvement of gamma-aminobutyric acid in the actions of ethanol.Eur. J. Pharmacol. 89: 53–62.
Mash, D. C., Flyn, D. D., and Potter, L. T. (1985). Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.Science 228: 1115–1117.
McIllwain, J., and Rodnight, R. (1962).Practical Neurochemistry, Litte, Brown, Boston.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease.Neurology 34: 939–944.
McKinney, M., and Coyle, J. T. (1982). Regulations of neocortical muscarinic receptors: Effects of drug treatment and lesions.J. Neurosci. 2: 97–105.
Meyer, R. E. (1986). Anxiolytics and the alcoholic patient.J. Stud. Alcohol 47: 269–273.
Mohler, H., and Okada, T. (1978). The benzodiazepine receptor in normal and pathological human brain.Br. J. Psychiat. 133: 261–268.
Munson, P. J. (1987).A User's Guide to LIGAND, National Institutes of Health, Bethesda, Md.
Nordberg, A., Larsson, C., Perdahl, E., and Winblad, B. (1982). Cholinergic activity in hippocampus in chronic alcoholism.Drug. Alcohol Depend 10: 333–344.
Nordberg, A., Larsson, C., Perdahl, E., and Winblad, B. (1983). Changes in cholinergic activity in human hippocampus following chronic alcohol abuse.Pharmacol. Biochem. Behav. 18: (Suppl. 1): 397–400.
Paul, S. M., Marangos, P. J., and Skolnick, P. (1981). The benzodiazepine-GABA-chloride ionophore receptor complex: Common site of minor tranquilizer action.Biol. Psychiat. 16: 213–229.
Perry, E. K., Perry, R. H., Smith, C. J., Purohit, D., Bonham, J. Dick, D. J., Candy, J. M., Edwardson, J. A., and Fairbairn, A. (1986). Cholinergic receptors in cognitive disorders.Can. J. Neurol. Sci. 13: 521–527.
Rabin, R. A., Wolfe, B. B., Dibner, M. D.,et al. (1980). Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57 mice.J. Pharmacol. Exp. Ther. 213: 491–496.
Reisberg, B. (1983). Clinical presentation, diagnosis, and symptomatology of age-associated cognitive decline and Alzheimer's disease. In Reisberg, B. (ed.),Alzheimer's Disease, Free Press, New York, pp. 173–187.
Reisine, T. D., Overstreet, D., Gale, K., Rossor, M., Iversen, L., and Yamamura, H. I. (1980). Benzodiazepine receptors: The effect of GABA on their characteristics in human brain and their alteration in Huntington's disease.Brain Res. 199: 79–88.
Richards, J. G., and Mohler, H. (1984). Benzodiazepine receptors.Neuropharmacoloty 23 (No. 2B): 233–242.
Riley, J. N., and Walker, D. W. (1978). Morphological alterations in hippocampus after long-term alcohol consumption in mice.Science 102: 646–648.
Rottenberg, H. (1985). Alcohol modulation of benzodiazepine receptors.Alcohol 2: 203–207.
Salmon, D. P., Butters, N., and Schuckit, M. (1986). Memory for temporal order and frequency of occurrence in detoxified alcoholics.Alcohol 3: 323–329.
Samson, Y., Hantraye, P., Baron, J. C., Soussaline, F., Comar, D., and Maziere, M. (1985). Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography.Eur. J. Pharmacol. 110: 247–251.
SAS Institute (1985).SAS user's Guide: Statistics, SAS Institute Inc., Cary, N.C.
Scatchard, G. (1949). The attractions of proteins for small molecules and ions.Ann. N.Y. Acad. Sci. 51: 660–672.
Skullerud, K. (1985). Variations in the size of the human brain. Influence of age, sex, body length, body mass index, alcoholism, Alzheimer changes, and cerebral atherosclerosis.Acta Neurol. Scand. 102: 1–94.
Smith, T. L. (1983). Influence of chronic ethanol consumption on muscarinic cholinergic receptors and their linkage to phospholipid metabolism in mouse synaptosomes.Neuropharmacology 22: 661–663.
Snyder, S. H. (1984). Drug and neurotransmitter receptors in the brain.Science 224: 22–31.
Snyder, S. H., and Goodman, R. R. (1980). Multiple neurotransmitter receptors.J. Neurochem. 35: 5–15.
Speth, R. C., Wastek, G. J., Johnson, P. C., and Yamamura, H. I. (1978). Benzodiazepine binding in human brain: Characterization using [3H]flunitrazepam.Life Sci. 22: 859–866.
Squires, R. F., Benson, D. I., Braestrup, C., Coupet, J., Klepner, C. A., Myers, V., and Beer, N. (1979). Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors.Pharmacol. Biochem. Behav. 10: 825–830.
Summers, K. W., Majovski, L. V., Marsh, G. M., Tachiki, K., and Kling, A. (1986). Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.N. Engl. J. Med. 315: 1241–1245.
Sun, G. Y., and Sun, A. Y. (1985). Ethanol and membrane lipids.Alcohol. Clin. Exp. Res. 9: 164–180.
Suzdak, P. D., Glowa, J. R., Crawley, J. N., Schwartz, R. D., Skolnik, P., and Paul, S. D. (1986). A selective imidazobenzodiazepine antagonist of ethanol in the rat.Science 234: 1243–1247.
Tabakoff, B., Munoz-Marcus, M., and Fields, J. Z. (1979). Chronic ethanol feeding produces an increase in muscarinic cholinergic receptors in mouse brain.Life Sci. 25: 2173–2180.
Tallman, J. F., Paul, S. M., Skolnick, P., and Gallager, D. W. (1980). Receptors for the age of anxiety: Pharmacology of the benzodiazepines.Science 207: 274–281.
Tarter, R. E., and Alterman, A. I. (1984). Neuropsychological deficits in alcoholics: Etiological considerations.J. Stud. Alcohol 45: 1–9.
Tarter, R. E., and Edwards, K. L. (1986). Multifactorial etiology of neuropsychological impairment in alcoholics.Alcohol. Clin. Exp. Res. 10: 128–135.
Ticku, M. K., Burch, T. P., and Davis, W. C. (1983). The interactions of ethanol with the benzodiazepine-GABA receptor-ionophore complex.Pharmacol. Biochem. Behav. 18 (Suppl. 1): 15–18.
Tollefson, G. G., and Gade, J. (1983). A comparison of human muscarinic cholinergic receptor properties subsequent to alcohol abuse and senescence.Biol. Psychiat. 18: 481–491.
Tollefson, G. D., Senogles, S. E., and Frey, W. H., II (1983). Ionic regulation of antagonist binding to the human muscarinic cholinergic receptor of caudata nucleus.J. Psychiat. Res. 17: 275–283.
Tran, V. T., Snyder, S. H., Major, L. F., and Hawley, R. J. (1981). GABA receptors are increased in brains of alcoholics.Ann. Neurol. 9: 289–292.
Unden, A., Meyerson, B., Winblad, B., Sachs, C., and Bartfai, T. (1983). Postmortem changes in binding to the muscarinic receptor from human cerebral cortex.J. Neurochem. 41: 102–106.
Victor, M., Adams, R. D., and Collins, G. H. (1971).The Wernicke-Korsakoff Syndrome: A Clinical and Pathological Study of 245 Patients, 82 with Post-mortem Examinations, F. A. Davis, Philadelphia.
Volicer, L., and Biagioni, T. M. (1982). Effect of ethanol administration and withdrawal on benzodiazepine receptor binding in the rat brain.Neuropharmacology 21: 283–286.
Walker, D. W., Hunter, B. E., and Abraham, C. W. (1981). Neuroanatomical and functional deficits subsequent to chronic ethanol administration in animals.Alcohol. Clin. Exp. Res. 5: 267–282.
Whalley, L. J. (1979). Alcohol consumption in 50 men alcoholics and a matched control group in Scotland.J. Stud. Alcohol 40: 117–119.
Whitehouse, P. J., Lynch, D., and Kuhar, M. J. (1984). Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process.J. Neurochem. 43: 553–559.
Whitehouse, P. J., Trifiletti, R. R., Jones, B. E., Folstein, S., Price, D. L., Snyder, S. H., and Kuhar, M. J. (1985). Neurotransmitter receptor alterations in Huntington's disease: Autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.Ann. Neurol. 18: 202–210.
Yamamura, H. I., and Snyder, S. H. (1974a). Muscarinic cholinergic binding in rat brain.Proc. Natl. Acad. Sci USA 71: 1725–1729.
Yamamura, H. I., and Snyder, S. H. (1974b). Postsynaptic localization of muscarinic cholinergic receptor binding in rat hippocampus.Brain Res. 78: 320–326.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Freund, G., Ballinger, W.E. Loss of muscarinic cholinergic receptors from the temporal cortex of alcohol abusers. Metabolic Brain Disease 4, 121–141 (1989). https://doi.org/10.1007/BF00999390
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00999390